Skip to main content
Publications
Willis TA, Hartley S, Glidewell L, Farrin AJ, Lawton R, McEachan RRC, Ingleson E, Heudtlass P, Collinson M, Clamp S, Hunter C, Ward V, Hulme C, Meads D, Bregantini D , Carder P, Foy R. Action to support practices implement research evidence (ASPIRE): protocol for a cluster-randomised evaluation of adaptable implementation packages targeting 'high impact' clinical practice recommendations in general practice . Implement Sci. 2016 Feb 29;11(25). doi: 10.1186/s13012-016-0387-5
Webb S, Ware JE, Forsythe A, Yang M, Badia X, Nelson LM , Signorovitch JE, McLeod L , Maldonado M, Zgliczylski W, De Block C, Portocarrero-Ortiz L, Gadelha MR. Treatment effectiveness of pasireotide on health-related quality of life in patients with Cushing's disease . Eur J Endocrinol. 2014 Jul;171(1):89-98. doi: 10.1530/EJE-13-1013
Samelson EJ, Miller PD, Christiansen C, Daizedeh NS, Grazette L, Anthony MS , Egbuna O, Wang A, Siddhanti SR, Cheung AM, Franchimont N, Kiel DP. RANKL inhibition with denosumab does not influence 3-year progression of aortic calcification or incidence of adverse cardiovascular events in postmenopausal women with osteoporosis and high cardiovascular risk . J Bone Miner Res. 2014 Feb;29(2):450-7. doi: 10.1002/jbmr.2043